Session 3 – Accelerating Biomedical Innovations
Date: 22 July (Wednesday) 12:20 – 13:50 (GMT+8)
Venue: 701EF, 7F, TaiNEX2 / Online event platform
Dan Wang MD is the Head of Johnson & Johnson Innovation in Asia Pacific, responsible for managing a portfolio of co-investments spanning across all three business sectors and expanding external networks within the innovation ecosystem.
Dan has over 20 years’ experience in the life sciences sector. Prior to joining Johnson & Johnson Innovation, Dan worked with Becton Dickinson (BD), e-Capital Corporation， Express Scripts and Johnson & Johnson by leading the local and global Research & Development, Medical Affairs and clinical research teams. Dan has a strong track record in strategic innovation, identifying new product opportunities and external partnerships.
Dan holds MD and MSc degrees from Peking University as well as an MBA from Goizueta Business School, and an MPH from Rollins School of Public Health at Emory University, Atlanta.
Speech title & Synopsis